The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation

Idiopathic pneumonia syndrome (IPS) refers to a diffuse, noninfectious, acute lung injury after hematopoietic stem cell transplantation. Historically, IPS is associated with respiratory failure and mortality rates exceeding 50%. Preclinical studies have implicated tumor necrosis factor-α as an impor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Yanik, Gregory A., Ho, Vincent T., Levine, John E., White, Eric S., Braun, Thomas, Antin, Joseph H., Whitfield, Joel, Custer, Joseph, Jones, Dawn, Ferrara, James L. M., Cooke, Kenneth R.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2008
Assuntos:
Clinical Trials and Observations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3045267/
https://ncbi.nlm.nih.gov/pubmed/18664626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-03-143412
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares